293 related articles for article (PubMed ID: 28477388)
41. Primary giant cell tumor of soft tissue of the groin - a case of 46 years duration.
Boneschi V; Parafioriti A; Armiraglio E; Gaiani F; Brambilla L
J Cutan Pathol; 2009 Oct; 36 Suppl 1():20-4. PubMed ID: 19222697
[TBL] [Abstract][Full Text] [Related]
42. A Comparative Analysis of p63 Expression in Giant Cell Tumour (GCT), Central Giant Cell Granuloma (CGCG) and Peripheral Giant Cell Granuloma (PGCG).
Nagar SR; Bansal S; Jashnani K; Sinha A; Desai RS
Head Neck Pathol; 2020 Sep; 14(3):733-741. PubMed ID: 31873936
[TBL] [Abstract][Full Text] [Related]
43. CD33+ CD14- phenotype is characteristic of multinuclear osteoclast-like cells in giant cell tumor of bone.
Forsyth RG; De Boeck G; Baelde JJ; Taminiau AH; Uyttendaele D; Roels H; Praet MM; Hogendoorn PC
J Bone Miner Res; 2009 Jan; 24(1):70-7. PubMed ID: 18767926
[TBL] [Abstract][Full Text] [Related]
44. Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone.
Evdokiou A; Atkins GJ; Bouralexis S; Hay S; Raggatt LJ; Cowled PA; Graves SE; Clayer M; Findlay DM
Int J Oncol; 2001 Sep; 19(3):625-32. PubMed ID: 11494046
[TBL] [Abstract][Full Text] [Related]
45. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
[TBL] [Abstract][Full Text] [Related]
46. Expression of H3.3 G34W Distinguishes Giant Cell Tumor of Bone From Its Major Giant Cell-containing Bone and Soft Tissue Mimics, in Particular Aneurysmal Bone Cyst and Giant Cell Tumor of Soft Tissue.
Creytens D
Appl Immunohistochem Mol Morphol; 2020; 28(5):e47-e48. PubMed ID: 29489506
[No Abstract] [Full Text] [Related]
47. Giant cell tumour of bone: morphological, biological and histogenetical aspects.
Werner M
Int Orthop; 2006 Dec; 30(6):484-9. PubMed ID: 17013643
[TBL] [Abstract][Full Text] [Related]
48. Giant Cell Tumor of Bone With Cartilage Matrix: A Clinicopathologic Study of 17 Cases.
Brčić I; Yamani F; Inwards CY; Sumathi V; Dodd L; Kreiger PA; Sittampalam K; Allred TR; Kashofer K; Liegl-Atzwanger B; Kerr DA; Nielsen GP; Rosenberg AE
Am J Surg Pathol; 2020 Jun; 44(6):748-756. PubMed ID: 32412716
[TBL] [Abstract][Full Text] [Related]
49. Characterization of MicroRNA Expression Profiles in Patients with Giant Cell Tumor.
Qin S; He NB; Yan HL; Dong Y
Orthop Surg; 2016 May; 8(2):212-9. PubMed ID: 27384730
[TBL] [Abstract][Full Text] [Related]
50. [Factors related to biologic behavior in giant cell tumor of bone].
Ran XY; Huang J; Zhang HZ; Jiang ZM; Chen J
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):669-74. PubMed ID: 24433729
[TBL] [Abstract][Full Text] [Related]
51. Giant cell tumors of soft tissue: a clinicopathologic study of 18 benign and malignant tumors.
O'Connell JX; Wehrli BM; Nielsen GP; Rosenberg AE
Am J Surg Pathol; 2000 Mar; 24(3):386-95. PubMed ID: 10716152
[TBL] [Abstract][Full Text] [Related]
52. Soft tissue giant cell tumor of low malignant potential.
Icihikawa K; Tanino R
Tokai J Exp Clin Med; 2004 Sep; 29(3):91-5. PubMed ID: 15595466
[TBL] [Abstract][Full Text] [Related]
53. Differential expression of filamin B splice variants in giant cell tumor cells.
Tsui JC; Lau CP; Cheung AC; Wong KC; Huang L; Tsui SK; Kumta SM
Oncol Rep; 2016 Dec; 36(6):3181-3187. PubMed ID: 27779699
[TBL] [Abstract][Full Text] [Related]
54. PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone.
Cowan RW; Singh G; Ghert M
J Orthop Res; 2012 Jun; 30(6):877-84. PubMed ID: 22102368
[TBL] [Abstract][Full Text] [Related]
55. Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration.
Zheng MH; Fan Y; Smith A; Wysocki S; Papadimitriou JM; Wood DJ
J Cell Biochem; 1998 Jul; 70(1):121-9. PubMed ID: 9632113
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone.
Wang T; Yin H; Wang J; Li Z; Wei H; Liu Z; Wu Z; Yan W; Liu T; Song D; Yang X; Huang Q; Zhou W; Xiao J
Oncotarget; 2015 Aug; 6(22):18980-96. PubMed ID: 26053181
[TBL] [Abstract][Full Text] [Related]
57. Incidence and demographics of giant cell tumor of bone in The Netherlands: First nationwide Pathology Registry Study.
Verschoor AJ; Bovée JVMG; Mastboom MJL; Sander Dijkstra PD; Van De Sande MAJ; Gelderblom H
Acta Orthop; 2018 Oct; 89(5):570-574. PubMed ID: 29987945
[TBL] [Abstract][Full Text] [Related]
58. Comparison of cytologic features of giant-cell tumor and giant-cell tumor of tendon sheath.
Gupta K; Dey P; Goldsmith R; Vasishta RK
Diagn Cytopathol; 2004 Jan; 30(1):14-8. PubMed ID: 14696139
[TBL] [Abstract][Full Text] [Related]
59. Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha.
Rao VH; Singh RK; Delimont DC; Finnell RH; Bridge JA; Neff JR; Garvin BP; Pickering DL; Sanger WG; Buehler BA; Schaefer GB
Int J Oncol; 1999 Feb; 14(2):291-300. PubMed ID: 9917505
[TBL] [Abstract][Full Text] [Related]
60. Keratin-positive giant cell-rich tumors of soft tissue with HMGA2::NCOR2 fusions.
Weigelt MA; Azzato EM; Habermehl GK; Billings SD; Ko JS; Fritchie KJ
J Cutan Pathol; 2023 Nov; 50(11):977-982. PubMed ID: 37496152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
